Scientech Research’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DFO
Scientech Research's NUVB Position: Q2 2026 in Review
Scientech Research sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 15,017 shares — an estimated $64.4K sold.
Scientech Research first reported a position in NUVB in Q1 2026 and held it in 1 quarter. The position peaked at $64.4K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Scientech Research reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 15,017 Nuvation Bio shares in Q2 2026, an estimated $64.4K.
- Scientech Research first reported a position in Nuvation Bio in Q1 2026 and held it in 1 quarter.
- Scientech Research's Nuvation Bio position peaked at $64.4K in Q1 2026.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.